The American Thoracic Society is extremely concerned with today’s announcement about changes in how the EPA evaluates the costs and benefits of environmental policy. While the details of economic analysis of environmental regulations are complex, the guiding principle is remarkably simple: compare all the costs and benefits of agency actions. The proposed changes in how costs and benefits are evaluated will sufficiently degrade the credibility of economic analysis conducted at the EPA to the point that it is no longer able to function as an objective policy analysis tool.Read more
The Environmental Protection Agency’s Safer Choice program approved eight cleaning product ingredients submitted by the American Cleaning Institute (ACI) for inclusion in its Safer Chemical Ingredients List (SCIL).
The decision marks the first time Safer Choice has approved a SCIL submission by a non-manufacturer.
Against the recommendation of the environmental, public health and even the electric power industry, this week the Environmental Protection Agency issued final rules to roll back regulations on mercury and toxic air emissions from our nation’s coal and oil-fired power plants. To justify taking such action, says the American Thoracic Society, the EPA ignored years of precedent – used by both Republican and Democratic Administrations – determining how the agency conducts cost benefit analysis of environmental regulations.Read more
The Trump Administration’s decision to roll back emission and mileage standards for cars and trucks is bad for respiratory health.Read more
Following reports of the Environmental Protection Agency’s move to implement broad changes that would relax environmental rules, the American Thoracic Society expressed disappointment with the plan.Read more
“Worse than the first, and still a bad idea,” was the reaction of ATS spokesperson Mary B Rice, MD, MPH, to the EPA’s proposed rule, “Strengthening Transparency in Regulatory Science.”Read more
The Society for Risk Analysis (SRA) inducted William Ruckelshaus to the Pantheon of Risk Analysis. The Pantheon, established in 2008, recognizes luminaries and visionaries in risk analysis and serves to illustrate how the field contributes to the advancement of knowledge and public good.Read more
Should you take omega-3 pills? Or try to have two to servings of omega-3 rich fish a week, as the American Heart Association recommends? It may seem a bit murky if you follow headlines about nutrition and health. That’s why researchers at the Intermountain Healthcare Heart Institute continue to research the potential benefits and risks of this popular supplement, especially when it comes to prostate cancer risk and heart health.